Silvia M. Ilie
Dijon, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 25 publications
Human endogenous retroviruses as immune-related prognostic biomarkers in pancreatic cancer.
Journal: BMC cancer
Published: March 29, 2026
An expression signature of 19 human endogenous retroviruses identifies immunogenic luminal breast cancers likely to respond to immunotherapy.
Journal: Frontiers in oncology
Published: October 19, 2025
Chemo-prAIdict Breast: A deep learning solution for predicting residual disease on biopsies of breast cancer patients treated with neoadjuvant chemotherapy.
Journal: European journal of cancer (Oxford, England : 1990)
Published: July 11, 2025
Cancer-associated fibroblasts and their prognostic role in colorectal cancer: review and meta-analysis.
Journal: Frontiers in oncology
Published: May 25, 2025
Prevalence, clinicopathologic features and long-term overall survival of early breast cancer patients eligible for adjuvant abemaciclib and/or ribociclib.
Journal: NPJ breast cancer
Published: November 01, 2024
Real-world prevalence, treatment and survival of "high risk" early breast cancer, with mandatory testing of gBRCA1/2 mutation according to the OlympiA trial inclusion criteria: Data from a population-based registry.
Journal: Breast (Edinburgh, Scotland)
Published: July 02, 2024
Pathologic and immunohistochemical prognostic markers in residual triple-negative breast cancer after neoadjuvant chemotherapy.
Journal: Frontiers in oncology
Published: October 08, 2023
Pathologic complete response and survival in HER2-low and HER2-zero early breast cancer treated with neoadjuvant chemotherapy.
Journal: Breast cancer (Tokyo, Japan)
Published: June 10, 2023
Clinical Utility of Genomic Tests Evaluating Homologous Recombination Repair Deficiency (HRD) for Treatment Decisions in Early and Metastatic Breast Cancer.
Journal: Cancers
Published: December 13, 2022
Taxane rechallenge during metastatic disease in HER-2 negative breast cancer patients: Clinical activity, tolerance and survival results.
Journal: Breast (Edinburgh, Scotland)
Published: October 14, 2022
Efficacy of Chemotherapy Plus Bevacizumab in Recurrent Glioblastoma Multiform: A Real-life Study.
Journal: Anticancer research
Published: September 25, 2022
Molecular intrinsic subtypes, genomic, and immune landscapes of BRCA-proficient but HRD-high ER-positive/HER2-negative early breast cancers.
Journal: Breast cancer research : BCR
Published: July 22, 2022
Last Updated: 09/26/2026